Clinical trial
Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
NCT00043381 · Astex Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00043381 |
|---|---|
| Title | Decitabine Versus Supportive Care in Adults With Advanced-stage MDS |
| Official title | A Randomized, Open-label, Phase III Trial of Decitabine (5-aza-2'Deoxycytidine) Versus Supportive Care in Adults With Advanced-stage Myelodysplastic Syndrome |
| Lead sponsor | Astex Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | decitabine (5-aza-2'deoxycytidine) |
| Enrollment | 160 |
| Start date | Apr 1, 2001 |
| Primary completion | Nov 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | Aug 12, 2002 |
| Last update posted | Aug 2, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: